Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

[Ocular brucellosis].

Mesquida M, Llorenç V, Cervera C, Adán A.

Med Clin (Barc). 2013 Mar 16;140(6):284. doi: 10.1016/j.medcli.2012.07.008. Epub 2012 Sep 17. Spanish. No abstract available.

PMID:
22995842
2.

Ocular brucellosis vs Vogt-Koyanagi-Harada syndrome.

Goldstein DA, Tessler HH.

Arch Ophthalmol. 2006 Apr;124(4):608-9; author reply 609. No abstract available.

PMID:
16606901
3.

Ocular involvement of brucellosis.

Bazzazi N, Yavarikia A, Keramat F.

Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):95-7. doi: 10.4103/0974-9233.106407.

4.

Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].

Alp E, Koc RK, Durak AC, Yildiz O, Aygen B, Sumerkan B, Doganay M.

BMC Infect Dis. 2006 Apr 11;6:72.

5.

[Brucellosis in the human].

Ramin B, Macpherson P.

Praxis (Bern 1994). 2011 Mar 2;100(5):305-7. doi: 10.1024/1661-8157/a000452. German. No abstract available.

PMID:
21365562
6.

Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis.

Colmenero Castillo JD, Hernandez Marquez S, Reguera Iglesias JM, Cabrera Franquelo F, Rius Diaz F, Alonso A.

Chemotherapy. 1989;35(2):146-52.

PMID:
2667903
7.

Brucellosis and uveitis.

Karahocagil MK, Demirok A, Kiliç A, Cinal A, Caksen H, Yasar T.

Ann Ophthalmol (Skokie). 2008 Spring;40(1):48-50.

PMID:
18556983
8.

Bilateral severe visual loss in brucellosis.

Tunç M, Durukan H.

Ocul Immunol Inflamm. 2004 Sep;12(3):233-6.

PMID:
15385199
9.

Ocular complications associated with brucellosis in an endemic area.

Güngür K, Bekir NA, Namiduru M.

Eur J Ophthalmol. 2002 May-Jun;12(3):232-7.

PMID:
12113571
10.

Bilateral multifocal choroiditis with serous retinal detachment in a patient with Brucella infection: case report and review of the literature.

Rabinowitz R, Schneck M, Levy J, Lifshitz T.

Arch Ophthalmol. 2005 Jan;123(1):116-8. Review. No abstract available.

PMID:
15642826
11.

Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.

Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P.

Antimicrob Agents Chemother. 1985 Oct;28(4):548-51.

12.

[Brucellosis in a low incidence zone].

Palacios Vaca F, Lahoz Rallo B.

Aten Primaria. 1996 Mar 31;17(5):362, 364. Spanish. No abstract available.

PMID:
8722165
13.

Tricky brucellosis.

Yaghoobi MH, Siroos B, Foroumandi M, Gharabaghi MA.

BMJ Case Rep. 2013 May 24;2013. pii: bcr2013009522. doi: 10.1136/bcr-2013-009522.

14.

Brucellosis presenting with cough.

Rowen JI, Englund JA.

Pediatr Infect Dis J. 1995 Aug;14(8):721-2. No abstract available.

PMID:
8532438
15.

Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.

Hashemi SH, Gachkar L, Keramat F, Mamani M, Hajilooi M, Janbakhsh A, Majzoobi MM, Mahjub H.

Int J Infect Dis. 2012 Apr;16(4):e247-51. doi: 10.1016/j.ijid.2011.12.003. Epub 2012 Jan 30.

16.

Update on childhood brucellosis.

Roushan MR, Amiri MJ.

Recent Pat Antiinfect Drug Discov. 2013 Apr;8(1):42-6. Review.

PMID:
22812616
17.

Ocular involvement in brucellosis.

Sungur GK, Hazirolan D, Gurbuz Y, Unlu N, Duran S, Duman S.

Can J Ophthalmol. 2009 Oct;44(5):598-601. doi: 10.3129/i09-019.

PMID:
19789599
18.

Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.

Bayindir Y, Sonmez E, Aladag A, Buyukberber N.

J Chemother. 2003 Oct;15(5):466-71.

PMID:
14598939
19.

Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.

Vrioni G, Bourdakis A, Pappas G, Pitiriga V, Mavrouli M, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2014 Dec;58(12):7541-4. doi: 10.1128/AAC.03841-14. Epub 2014 Sep 22.

20.

[Brucellosis].

Okamura N.

Nihon Rinsho. 2003 Feb;61 Suppl 2:450-2. Review. Japanese. No abstract available.

PMID:
12722260

Supplemental Content

Support Center